chronic kidney disease chronic renal failure epidemiology forecast

Key Highlights

• Most diagnosed prevalent CKD patients were estimated in the US followed by EU4, the UK, and Japan.
• In the 7MM, around 16 million cases were estimated to be diagnosed for CKD, of which the US had 35% of the cases.
• Females were estimated to be slightly more than men in the 7MM.
• Age-specific cases of CKD were divided into 18–44 years, 45–64 years, and 65+ years. The oldest age group was estimated to have the highest patient share of the total diagnosed CKD.

DelveInsight’s “Chronic Kidney Disease (CKD) – Epidemiology – 2032” report delivers an in-depth understanding of CKD, historical and forecasted epidemiology of CKD in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Geography Covered

• The United States
• EU4 (Germany, France, Italy, and Spain) and the United Kingdom
• Japan

Study Period: 2019–2032

Chronic Kidney Disease (CKD) Disease Understanding

Chronic Kidney Disease (CKD) Overview

Chronic Kidney Disease (CKD) is defined as the presence of kidney damage or an estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73 m2, persisting for 3 months or more, irrespective of the cause. It is a state of progressive loss of kidney function, ultimately resulting in the need for renal replacement therapy (dialysis or transplantation).

There are usually no symptoms of kidney disease in the early stages. It may only be diagnosed if a blood or urine test is done for another reason and the results show a kidney problem. At a more advanced stage, symptoms can include tiredness, swollen ankles, feet, or hands, shortness of breath, feeling sick, and blood in the urine.

Chronic Kidney Disease (CKD) Diagnosis

CKD can be diagnosed using blood and urine tests. The eGFR blood test shows the efficiency with which the kidneys are working. Imaging tests such as an ultrasound, CT scan, X-ray, or MRI are also used.

Further details related to diagnosis are provided in the report…

Chronic Kidney Disease (CKD) Epidemiology

As the market is derived using patient-based model, the CKD epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by Prevalent Cases of CKD, Diagnosed Prevalent Cases of CKD, Gender-specific Diagnosed Prevalent Cases of CKD, Age-specific Diagnosed Prevalent cases of CKD, Complication-specific Diagnosed Prevalent cases of CKD, Stage-specific Diagnosed Prevalent Cases of CKD and Etiology-specific Diagnosed Prevalent Cases of CKD in the 7MM covering the United States, EU4 countries (Germany, France, Italy, and Spain) and the UK, and Japan from 2019 to 2032.

• The total diagnosed prevalent cases of CKD in the 7MM comprised approximately 16 million cases in 2022 and are projected to increase during the forecast period (2023–2032)
• According to DelveInsight estimates, the US accounted for approximately 5.6 million diagnosed cases.
• Among EU4 and the UK, the UK had the highest diagnosed prevalent population of CKD (approximately 2.3 million cases). On the other hand, Italy (0.7 million cases) had the lowest diagnosed prevalent population in EU4 and the UK countries and the 7MM.
• In 2022, 52% of cases of CKD were of females, while 48% of cases were of males in the 7MM.
• The severity-specific estimates showed that Stage III had been the most prevalent form of CKD among the diagnosed population.

KOL Views

To keep up with current market trends, we take KOLs and SMEs’ opinions working in the domain through primary research to fill the data gaps and validate our secondary research. Industry Experts contacted for insights on Chronic Kidney Disease (CKD) evolving treatment landscape, patient reliance on conventional therapies, patient therapy switching acceptability, drug uptake, along with challenges related to accessibility, including HCPs, Physicians, and others.

Delveinsight’s analysts connected with 10+ KOLs to gather insights; however, interviews were conducted with 5+ KOLs in the 7MM. Centers such as the Université Claude Bernard, France, Kings College Hospital, NHS Foundation Trust, the UK, National University in Niigata, Japan, etc., were contacted. Their opinion helps understand and validate current and emerging therapy treatment patterns or CKD market trends. This will support the clients in potential upcoming novel treatments by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

• The report covers a segment of key events, an executive summary, and a descriptive overview of Chronic Kidney Disease (CKD), explaining its causes, signs and symptoms, pathogenesis, and currently used diagnostic approaches.
• Comprehensive insight into the epidemiology segments and forecasts, disease progression, and diagnostic guidelines or algorithms have been provided.
• The report provides an edge while developing business strategies, understanding trends, expert insights/KOL views, and patient journey in the 7MM.
• A detailed review of current challenges in establishing the diagnosis.

Chronic Kidney Disease (CKD) Report Insights

• Patient Population
• Country-wise Epidemiology Distribution
• Gender-wise cases of Chronic Kidney Disease (CKD)
• Age-wise cases of Chronic Kidney Disease (CKD)
• Severity-wise cases of Chronic Kidney Disease (CKD)

Chronic Kidney Disease (CKD) Report Key Strengths

• Ten Years Forecast
• The 7MM Coverage
• Chronic Kidney Disease (CKD) Epidemiology Segmentation

Chronic Kidney Disease (CKD) Report Assessment

• Current Diagnostic Practices

Epidemiology Insights

• What are the disease risk, burdens, and unmet needs of Chronic Kidney Disease (CKD)? What will be the growth across the 7MM concerning the patient population with Chronic Kidney Disease (CKD)?
• What is the historical and forecasted Chronic Kidney Disease (CKD) patient pool in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan?
• Why are region-based differences in the diagnosed cases of the disease?
• Which gender has a higher prevalence of Chronic Kidney Disease (CKD)?
• Which age group of Chronic Kidney Disease (CKD) has a high patient share?
• Which severity stage has the highest number of cases among the diagnosed patients?

Reasons to Buy

• Insights on patient burden/disease, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand the age-specific CKD prevalent cases in varying geographies over the coming years.
• A detailed overview of gender-specific, age-specific, and severity-specific cases of CKD are the inclusions.
• To understand the perspective of key opinion leaders around the current challenges with establishing the diagnosis and insights on the recurrent and treatment-eligible patient pool.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.